Controlling retinal pigment epithelium injury after experimental detachment of the retina

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 3, 2007, Pages 1348-1354

  Iribarne, Maria ^a   Canto Soler, M Valeria ^a   Torbidoni, Vanesa ^a   Suburo, Angela M ^a  

^a UNIVERSIDAD AUSTRAL   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LECTIN; MELATONIN; PROPIDIUM IODIDE; SODIUM CHLORIDE; SULPIRIDE; DOPAMINE 2 RECEPTOR; MEMBRANE PROTEIN; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DARK ADAPTATION; ENUCLEATION; EPITHELIUM CELL; HISTOCHEMISTRY; ILLUMINATION; LECTIN BINDING; LIGHT DARK CYCLE; MALE; MOUSE; NONHUMAN; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA CONE; RETINA DETACHMENT; RETINA INJURY; TREATMENT OUTCOME; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL SURVIVAL; CYTOCHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; METABOLISM; PATHOLOGY; TIME;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; DARK ADAPTATION; EXTRACELLULAR MATRIX; HISTOCYTOCHEMISTRY; LECTINS; MALE; MELATONIN; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MODELS, ANIMAL; PHOSPHOPROTEINS; PIGMENT EPITHELIUM OF EYE; PROPIDIUM; RECEPTORS, DOPAMINE D2; RETINAL DETACHMENT; SULPIRIDE; TIME FACTORS;

EID: 34047256245     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0964     Document Type: Article

References (42)

1. de Juan E Jr, Loewenstein A, Bressler NM, Alexander J. Translocation of the retina for management of subfoveal choroidal neovascularization II: a preliminary report in humans. Am J Ophthalmol. 1998;125:635-646.
2. Stanga PE, Kychenthal A, Fitzke FW, et al. Retinal pigment epithelium translocation after choroidal neovascular membrane removal in age-related macular degeneration. Ophthalmology. 2002;109:1492-1498.
3. Endo EG, Yao XY, Marmor MF. Pigment adherence as a measure of retinal adhesion: dependence on temperature. Invest Ophthalmol Vis Sci. 1988;29:1390-1396.
4. Nandrot EF, Anand M, Sircar M, Finnemann SC. Novel function for αvβ5 integrin in retinal adhesion and its diurnal peak. Am J Physiol Cell Physiol. 2006;290:C1256-C1262.
5. Johnson LV, Hageman GS. Structural and compositional analyses of isolated cone matrix sheaths. Invest Ophthalmol Vis Sci. 1991;32:1951-1957.
6. Mieziewska KE, van Veen T, Murray JM, Aguirre GD. Rod and cone specific domains in the interphotoreceptor matrix. J Comp Neurol. 1991;308:371-380.
7. Johnson LV, Hageman GS, Blanks JC. Interphotoreceptor matrix domains ensheath vertebrate cone photoreceptor cells. Invest Ophthalmol Vis Sci. 1986;27:129-135.
8. Owczarek FR, Marak GE, Pilkerton AR. Retinal adhesion in light-and dark-adapted rabbits. Invest Ophthalmol. 1975;14:353-358.
9. Marmor MF, Mechanism of normal retinal adhesion. In: Ryan SJ, ed. Retina. St. Louis, MO: CV Mosby: 2001.
10. Faude F, Wendt S, Biedermann B, et al. Facilitation of artificial retinal detachment for macular translocation surgery tested in rabbit. Invest Ophthalmol Vis Sci. 2001;42:1328-1337.
11. Fang XY, Hayashi A, Cekic O, et al. Effect of Ca(2+)-free and Mg(2+)-free BSS Plus solution on the retinal pigment epithelium and retina in rabbits. Am J Ophthalmol. 2001;131:481-488.
12. Cahill GM, Besharse JC. Light-sensitive melatonin synthesis by Xenopus photoreceptors after destruction of the inner retina. Vis Neurosci. 1992;8:487-490.
13. Fukuhara C, Liu C, Ivanova TN, et al. Gating of the cAMP signaling cascade and melatonin synthesis by the circadian clock in mammalian retina. J Neurosci. 2004;24:1803-1811.
14. Green CB, Besharse JC. Retinal circadian clocks and control of retinal physiology. J Biol Rhythms. 2004;19:91-102.
15. Tosini G, Fukuhara C. Photic and circadian regulation of retinal melatonin in mammals. J Neuroendocrinol. 2003;15:364-369.
16. Kodjikian L, Richter T, Halberstadt M, et al. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol. 2005;243:917-925.
17. Anderson JM, Stevenson BR, Jesaitis LA, Goodenough DA, Mooseker MS. Characterization of ZO-1, a protein component of the tight junction from mouse liver and Madin-Darby canine kidney cells. J Cell Biol. 1988;106:1141-1149.
18. Barthel LK, Raymond PA. Improved method for obtaining 3-microns cryosections for immunocytochemistry. J Histochem Cytochem. 1990;38:1383-1388.
19. Doyle SE, Grace MS, McIvor W, Menaker M. Circadian rhythms of dopamine in mouse retina: the role of melatonin. Vis Neurosci. 2002;19:593-601.
20. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci. 1981;21:10-16.
21. Kroll AJ, Machemer R. Experimental retinal detachment in the owl monkey, 3: electron microscopy of retina and pigment epithelium. Am J Ophthalmol. 1968;66:410-427.
22. Nour M, Quiambao AB, Peterson WM, Al-Ubaidi MR, Naash MI. P2Y(2) receptor agonist INS37217 enhances functional recovery after detachment caused by subretinal injection in normal and rds mice. Invest Ophthalmol Vis Sci. 2003;44:4505-4514.
23. Lewis GP, Charteris DG, Sethi CS, Leitner WP, Linberg KA, Fisher SK. The ability of rapid retinal reattachment to stop or reverse the cellular and molecular events initiated by detachment. Invest Ophthalmol Vis Sci. 2002;43:2412-2420.
24. Lim JM, Byun S, Chung S, et al. Retinal pigment epithelial cell behavior is modulated by alterations in focal cell-substrate contacts. Invest Ophthalmol Vis Sci. 2004;45:4210-4216.
25. Men G, Peyman GA, Kuo PC, et al. The effect of intraoperative retinal manipulation on the underlying retinal pigment epithelium: an experimental study. Retina. 2003;23:475-480.
26. Guerin CJ, Lewis GP, Fisher SK, Anderson DH. Recovery of photoreceptor outer segment length and analysis of membrane assembly rates in regenerating primate photoreceptor outer segments. Invest Ophthalmol Vis Sci. 1993;34:175-183.
27. Jaeschke H, Lemasters JJ. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology. 2003;125:1246-1257.
28. Nandrot EF, Kim Y, Brodie SE, Huang X, Sheppard D, Finnemann SC. Loss of synchronized retinal phagocytosis and age-related blindness in mice lacking alphavbeta5 integrin. J Exp Med. 2004;200:1539-1545.
29. Nandrot EF, Anand M, Sircar M, Finnemann SC. Novel role for αvβ5-integrin in retinal adhesion and its diurnal peak. Am J Physiol Cell Physiol. 2006;290:C1256-C1262.
30. Nguyen-Legros J, Hicks D. Renewal of photoreceptor outer segments and their phagocytosis by the retinal pigment epithelium. Int Rev Cytol. 2000;196:245-313.
31. White MP, Fisher LJ. Effects of exogenous melatonin on circadian disc shedding in the albino rat retina. Vision Res. 1989;29:167-179.
32. Witkovsky P. Dopamine and retinal function. Doc Ophthalmol. 2004;108:17-40.
33. Cahill GM, Grace MS, Besharse JC. Rhythmic regulation of retinal melatonin: metabolic pathways, neurochemical mechanisms, and the ocular circadian clock. Cell Mol Neurobiol. 1991;11:529-560.
34. Doi M, Yujnovsky I, Hirayama J, et al. Impaired light masking in dopamine D2 receptor-null mice. Nat Neurosci. 2006;9:732-734.
35. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine. 2005;27:119-130.
36. Osborne NN, Nash MS, Wood JP. Melatonin counteracts ischemia-induced apoptosis in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 1998;39:2374-2383.
37. Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res. 2004;78:1069-1075.
38. Sahna E, Parlakpinar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res. 2005;54:491-495.
39. Er H, Turkoz Y, Mizrak B, Parlakpinar H. Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. Ophthalmologica. 2006;220:17-22.
40. Hageman GS, Marmor MF, Yao XY, Johnson LV. The interphotoreceptor matrix mediates primate retinal adhesion. Arch Ophthalmol. 1995;113:655-660.
41. Wiechmann AF. Regulation of gene expression by melatonin: a microarray survey of the rat retina. J Pineal Res. 2002;33:178-185.
42. Michael JC, Pak J, Pulido J, de Venecia G. Central serous chorioretinopathy associated with administration of sympathomimetic agents. Am J Ophthalmol. 2003;136:182-185.